Literature DB >> 23806526

Ossifying fibromyxoid tumor presenting EP400-PHF1 fusion gene.

Makoto Endo1, Kenichi Kohashi, Hidetaka Yamamoto, Takeaki Ishii, Tatsuya Yoshida, Tomoya Matsunobu, Yukihide Iwamoto, Yoshinao Oda.   

Abstract

Ossifying fibromyxoid tumor is a rare soft tissue tumor of borderline malignancy and uncertain differentiation. Recently, a novel fusion gene, EP400-PHF1, was discovered in ossifying fibromyxoid tumor; however, its relation to this type of tumor has been uncertain because the EP400-PHF1 fusion gene has been successfully detected in only 1 case. We present an ossifying fibromyxoid tumor case with the EP400-PHF1 fusion gene detected by reverse transcriptase polymerase chain reaction, along with compatible cytogenetic data showing a t(6;12)(p21;q24.3) translocation. Our results suggest that the EP400-PHF1 fusion gene is a reproducible finding in ossifying fibromyxoid tumor.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EP400; Fusion gene; Ossifying fibromyxoid tumor; PHF1; RT-PCR

Mesh:

Substances:

Year:  2013        PMID: 23806526     DOI: 10.1016/j.humpath.2013.04.003

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  12 in total

1.  Fusion of the Genes PHF1 and TFE3 in Malignant Chondroid Syringoma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Marius Lund-Iversen; Assia Bassarova; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2019 Sep-Oct       Impact factor: 4.069

Review 2.  Diagnosis and Management of Subcutaneous Soft Tissue Sarcoma.

Authors:  Makoto Endo; Nokitaka Setsu; Toshifumi Fujiwara; Takeaki Ishii; Makoto Nakagawa; Kenichiro Yahiro; Atsushi Kimura; Eijiro Shimada; Yasuharu Nakashima; Yoshihiro Matsumoto
Journal:  Curr Treat Options Oncol       Date:  2019-05-25

Review 3.  Recent advances in the histological and molecular classification of endometrial stromal neoplasms.

Authors:  Joana Ferreira; Ana Félix; Jochen K Lennerz; Esther Oliva
Journal:  Virchows Arch       Date:  2018-10-15       Impact factor: 4.064

4.  Novel ZC3H7B-BCOR, MEAF6-PHF1, and EPC1-PHF1 fusions in ossifying fibromyxoid tumors--molecular characterization shows genetic overlap with endometrial stromal sarcoma.

Authors:  Cristina R Antonescu; Yun-Shao Sung; Chun-Liang Chen; Lei Zhang; Hsiao-Wei Chen; Samuel Singer; Narasimhan P Agaram; Andrea Sboner; Christopher D Fletcher
Journal:  Genes Chromosomes Cancer       Date:  2013-11-28       Impact factor: 5.006

5.  Primary pulmonary clear cell sarcoma-the first two reported cases.

Authors:  Giap Hean Goh; Ming Teh; Tomas Vanecek; Cesar Moran; Fredrik Petersson
Journal:  Virchows Arch       Date:  2016-04-25       Impact factor: 4.064

6.  Identification of key gene signatures for the overall survival of ovarian cancer.

Authors:  Akash Pawar; Oindrila Roy Chowdhury; Ruby Chauhan; Sanjay Talole; Atanu Bhattacharjee
Journal:  J Ovarian Res       Date:  2022-01-20       Impact factor: 4.234

7.  Discovery of an H3K36me3-Derived Peptidomimetic Ligand with Enhanced Affinity for Plant Homeodomain Finger Protein 1 (PHF1).

Authors:  Isabelle A Engelberg; Jiuyang Liu; Jacqueline L Norris-Drouin; Stephanie H Cholensky; Samantha A Ottavi; Stephen V Frye; Tatiana G Kutateladze; Lindsey I James
Journal:  J Med Chem       Date:  2021-05-17       Impact factor: 8.039

Review 8.  Oncogenic roles of SMARCB1/INI1 and its deficient tumors.

Authors:  Kenichi Kohashi; Yoshinao Oda
Journal:  Cancer Sci       Date:  2017-04-12       Impact factor: 6.716

9.  Primary malignant ossifying fibromyxoid tumour of the bone. A clinicopathologic and molecular report of two cases.

Authors:  Marta Sbaraglia; Elena Bellan; Marco Gambarotti; Alberto Righi; Lucia Zanatta; Luisa Toffolatti; Angelo P Dei Tos
Journal:  Pathologica       Date:  2020-11-03

10.  Cytogenetic and molecular profile of endometrial stromal sarcoma.

Authors:  Francesca Micci; Ludmila Gorunova; Antonio Agostini; Lene E Johannessen; Marta Brunetti; Ben Davidson; Sverre Heim; Ioannis Panagopoulos
Journal:  Genes Chromosomes Cancer       Date:  2016-08-09       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.